Literature DB >> 24556845

Permissibility of Mongolian gerbil for Angiostrongylus cantonensis infection and utility of this animal model for anthelmintic studies.

Yongfang Wei1, Qing Hong, Daixiong Chen, Chenjie Liang, Haiying Liu, Xiaodong Luo, Xunmin Zhu.   

Abstract

The Mongolian gerbil (Meriones unguiculatus) has been indicated to be a useful experimental model host for studying nematode. To understand the possibility of the Mongolian gerbil as an animal model of Angiostrongylus cantonensis infection, we investigated the development, migration, and tissue distribution of A. cantonensis and pathological changes in the brain and lungs of the infected Mongolian gerbils. The first stage larvae of A. cantonensis in the stool of the infected gerbils were examined by direct smear method at 45th day postinfection (PI). In addition, a group of the infected gerbils were orally fed with albendazole (100 mg/kg/day/gerbil) at the 8th day PI and continued for 3 consecutive days. The results showed that mortality rate of Mongolian gerbils infected with 10 third stage larvae of A. cantonensis was about 62% at the 30th day PI; the peak period of death was from the 23rd to 30th day PI. About 93% (27/29) of the worms in survivors of infected gerbils could develop to complete sexual maturity at the 46th day PI, and the examinations of 12 gerbils in G3 group revealed that first stage larvae of A. cantonensis could be found in the feces of 4 gerbils at the 45th day PI. About 80% of the worms were in the brain of infected gerbils and 20% in the lungs from the 23rd to 25th day PI; during migration of the worms from the brain to lungs, more than 90% of the worms arrived to the lungs and less than 10% of them still stayed in the brain during from the 45th to 46th day PI. Pathological examination revealed that injuries induced by A. cantonensis in infected gerbils were characterized by eosinophilic meningitis and granulomatous pneumonia. Otherwise, albendazole exhibited a good larvicidal activity in the infected Mongolian gerbils. In contrast with infected control group, no gerbils died in administering albendazole, no worms were recovered, and no nervous system symptoms caused by the infection occurred at the 26th day PI. These findings clearly indicated that Mongolian gerbils should be a potential incomplete permissive host for A. cantonensis and are very susceptive to A. cantonensis infection. Moreover, it has been certified that gerbils as an experimental animal can be used in screening of drug against A. cantonensis. The study provides us a new, selectable experimental animal model for research of A. cantonensis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24556845     DOI: 10.1007/s00436-014-3813-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  37 in total

1.  Differences of larval development and pathological changes in permissive and nonpermissive rodent hosts for Angiostrongylus cantonensis infection.

Authors:  Lisi OuYang; Jie Wei; Zhongdao Wu; Xin Zeng; Youlan Li; Yu Jia; Yuxin Ma; Mali Zhan; Wanlong Lei
Journal:  Parasitol Res       Date:  2012-07-10       Impact factor: 2.289

Review 2.  Human Angiostrongylus cantonensis: an update.

Authors:  Q-P Wang; Z-D Wu; J Wei; R L Owen; Z-R Lun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-05       Impact factor: 3.267

3.  [Antigen analysis of Angiostrongylus cantonensis in different developmental stages].

Authors:  Hua Li; Xiao-guang Chen; Hao-xian Shen; Hong-juan Peng; Xing-cun Zhao
Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi       Date:  2005-02-28

4.  The use of albendazole and diammonium glycyrrhizinate in the treatment of eosinophilic meningitis in mice infected with Angiostrongylus cantonensis.

Authors:  Y Li; J-P Tang; D-R Chen; C-Y Fu; P Wang; Z Li; W Wei; H Li; W-Q Dong
Journal:  J Helminthol       Date:  2011-12-13       Impact factor: 2.170

5.  Differences in responses of rat- and guinea-pig-eosinophils to eosinophil chemotactic factors derived from Angiostrongylus cantonensis.

Authors:  K Ishida; K Yoshimura
Journal:  Parasite Immunol       Date:  1990-05       Impact factor: 2.280

6.  Pathological changes in the brains of rabbits experimentally infected with Angiostrongylus cantonensis after albendazole treatment: histopathological and magnetic resonance imaging studies.

Authors:  Lian-Chen Wang; Shih-Ming Jung; Chien-Chuan Chen; Ho-Fai Wong; Dinah-Pingni Wan; Yung-Liang Wan
Journal:  J Antimicrob Chemother       Date:  2005-11-30       Impact factor: 5.790

7.  Fatal autochthonous eosinophilic meningitis in a Jamaican child caused by Angiostrongylus cantonensis.

Authors:  J F Lindo; C T Escoffery; B Reid; G Codrington; C Cunningham-Myrie; M L Eberhard
Journal:  Am J Trop Med Hyg       Date:  2004-04       Impact factor: 2.345

8.  Angiostrongylus cantonensis: role of eosinophils in the neurotoxic syndrome (Gordon-like phenomenon).

Authors:  O Perez; M Capron; M Lastre; P Venge; J Khalife; A Capron
Journal:  Exp Parasitol       Date:  1989-05       Impact factor: 2.011

9.  Matrix metalloproteinase-2, -9 and -13 are involved in fibronectin degradation of rat lung granulomatous fibrosis caused by Angiostrongylus cantonensis.

Authors:  Cheng-Chin Hsu; Shih-Chan Lai
Journal:  Int J Exp Pathol       Date:  2007-12       Impact factor: 1.925

10.  The first case of Angiostrongylus cantonensis eosinophilic meningitis diagnosed in the city of São Paulo, Brazil.

Authors:  Maria Cristina Carvalho do Espírito-Santo; Pedro Luiz Silva Pinto; Dan Jesse Gonçalves da Mota; Ronaldo César Borges Gryschek
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Mar-Apr       Impact factor: 1.846

View more
  3 in total

Review 1.  Central nervous system manifestations of Angiostrongylus cantonensis infection.

Authors:  Yuri C Martins; Herbert B Tanowitz; Kevin R Kazacos
Journal:  Acta Trop       Date:  2014-10-13       Impact factor: 3.112

Review 2.  Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies.

Authors:  John Jacob; Argon Steel; Zhain Lin; Fiona Berger; Katrin Zöeller; Susan Jarvi
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 9.079

3.  Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils.

Authors:  Yi-Sheng Sun; Yong Xia; Fang Xu; Hang-Jing Lu; Zi-An Mao; Meng Gao; Tian-Yuan Pan; Ping-Ping Yao; Zhen Wang; Han-Ping Zhu
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.